Inventor
LINDHOUT DARRIN ANTHONY
US26 patents
Patents
26 patentsUS9751924B2Sep 5, 2017
Methods of using compositions comprising fusion variants of FGF19 polypeptides for reducing glucose levels in a subject
NGM BIOPHARMACEUTICALS INC32 citations98
US9670260B2Jun 6, 2017
Compositions comprising fusion variants of FGF19 polypeptides
NGM BIOPHARMACEUTICALS INC34 citations98
US9580483B2Feb 28, 2017
Methods of using compositions comprising variants and fusions of FGF19 polypeptides for treatment of diabetes
NGM BIOPHARMACEUTICALS INC36 citations98
US9089525B1Jul 28, 2015
Methods of using compositions comprising variants and fusions of FGF19 polypeptides for reducing glucose levels in a subject
NGM BIOPHARMACEUTICALS INC37 citations98
US9963494B2May 8, 2018
Methods of using compositions comprising variants and fusions of FGF19 polypeptides for reducing glucose levels in a subject
NGM BIOPHARMACEUTICALS INC19 citations94
US9920118B2Mar 20, 2018
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC19 citations94
US9290557B2Mar 22, 2016
Compositions comprising variants and fusions of FGF19 polypeptides
NGM BIOPHARMACEUTICALS INC37 citations94
US9161966B2Oct 20, 2015
GDF15 mutein polypeptides
NGM BIOPHARMACEUTICALS INC29 citations93
US10413590B2Sep 17, 2019
Methods of using compositions comprising variants of FGF19 polypeptides for reducing body mass in a subject
NGM BIOPHARMACEUTICALS INC10 citations92
US9827291B2Nov 28, 2017
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC16 citations92
US9550819B2Jan 24, 2017
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC22 citations92
US10195250B2Feb 5, 2019
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC12 citations91
US9834586B2Dec 5, 2017
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC18 citations91
US9828415B2Nov 28, 2017
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC17 citations90
US10562965B2Feb 18, 2020
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC5 citations84
US10398758B2Sep 3, 2019
Compositions comprising variants of FGF19 polypeptides and uses thereof for the treatment of hyperglycemic conditions
NGM BIOPHARMACEUTICALS INC9 citations84
US10610568B2Apr 7, 2020
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC5 citations83
US10869909B2Dec 22, 2020
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC4 citations82
US10517929B2Dec 31, 2019
Pharmaceutical compositions comprising FGF19 variants
NGM BIOPHARMACEUTICALS INC9 citations82
US10323075B2Jun 18, 2019
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC8 citations82
US11530260B2Dec 20, 2022
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC2 citations73
US11358995B2Jun 14, 2022
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC2 citations71
US12173060B2Dec 24, 2024
Compositions and methods of use for treating metabolic disorders
NGM BIOPHARMACEUTICALS INC0 citations62
US11065302B2Jul 20, 2021
Compositions comprising fusion variants of FGF19 polypeptides
NGM BIOPHARMACEUTICALS INC0 citations62
US11066454B2Jul 20, 2021
Compositions comprising variants and fusions of FGF19 polypeptides
NGM BIOPHARMACEUTICALS INC0 citations62
US10758590B2Sep 1, 2020
Methods of using compositions comprising variants and fusions of FGF 19 polypeptides for treating diabetes
NGM BIOPHARMACEUTICALS INC0 citations52